Core Viewpoint - Weifu High-Tech has established a joint venture to enhance its business in the fully active suspension system sector, leveraging its technological advantages and distribution channels [1][2]. Group 1: Joint Venture Details - Weifu High-Tech's subsidiary, Weifu Jinning, will invest 220 million yuan (approximately 32.1 million USD) for a 55% stake in the newly formed Weifu Baolong Technology Co., Ltd., while Baolong Technology will invest 180 million yuan (approximately 26 million USD) for a 45% stake [1]. - The joint venture aims to synergize Weifu Jinning's fully active suspension motor hydraulic pump technology with Baolong Technology's suspension system distribution advantages to maximize commercial benefits for both shareholders [2]. Group 2: Company Background and Financials - Weifu High-Tech, originally established in 1958, focuses on the research, production, and sales of core automotive components, with its automotive parts business generating 11.01 billion yuan (approximately 1.58 billion USD) in revenue in 2024, accounting for 98.6% of total revenue [2]. - The company has significantly increased its R&D investment, with expenditures of 582 million yuan, 668 million yuan, and 690 million yuan from 2022 to 2024, totaling 1.94 billion yuan (approximately 280 million USD) over three years [2]. - Despite the increase in R&D spending, Weifu High-Tech faces challenges due to intensified market competition and declining investment income, with revenues of 11.17 billion yuan and 2.834 billion yuan in 2024 and Q1 2025, reflecting year-on-year changes of 0.67% and -2.38% respectively [3].

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Ke Yi City land project, with the controlling shareholder planning to develop the project instead [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Materials intends to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials [6] - Weifu High-Tech's subsidiary plans to establish a joint venture with Baolong Technology to expand the active suspension motor hydraulic pump business [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chen'an Technology's shareholder is transferring 6.27% of the company's shares to Hefei Guotou, aiming to introduce strategic investors [9] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, with stock trading suspended for up to 10 trading days [11] - Baolong Technology's subsidiary will collaborate with Weifu High-Tech's subsidiary to develop core components for the active suspension system [12] Group 4 - Zhongnong Lihua intends to acquire at least 50% of Taizhou Agricultural Supplies, enhancing its product and service range [13] - Weiling Co., Ltd.'s subsidiary has successfully acquired 74.3% of Jiayu Mining for 220 million yuan, focusing on expanding into the non-ferrous metal resource sector [14][15] - Hengshi Technology's subsidiary has been approved for public transfer of shares on the New Third Board [16] Group 5 - Xiang Teng New Materials plans to acquire an additional 12.5% stake in its subsidiary Shanghai Shangda for 25.3 million yuan [17] - ST Texin has extended its employee stock ownership plan by 12 months, reflecting confidence in the company's long-term development [18] - Baili Electric has issued a risk warning regarding its stock price increase, indicating no significant changes in fundamentals [19] Group 6 - Hu Silicon Industry plans to acquire minority stakes in three semiconductor companies for approximately 7.04 billion yuan [20][21] - Demais plans to change its controlling shareholder, leading to a temporary suspension of stock trading [22] - FAW Fuwei has received a notice from a well-known new energy brand for a project expected to generate 1.06 billion yuan in total sales over its lifecycle [23] Group 7 - Hangyang Co. plans to establish a subsidiary for a large modular cryogenic equipment manufacturing project with an estimated investment of 557 million yuan [24] - Jiewate intends to acquire 40.89% of Tianyi Hexin for 319 million yuan, enhancing its product line in the signal chain category [25] - Dingxin Communications has elected a new chairman following the resignation of the previous chairman [26][27] Group 8 - Aofei Entertainment plans to invest 10 million yuan in a partnership to indirectly invest in AI robotics company Xuan Yuan Technology [28] - Huaxi Energy's controlling shareholder has been detained, but the company states that operations remain normal [29] - Yihe Jiaye will change its stock name to "Ruimaite" starting May 21 [30] Group 9 - Zhongjin Environment will change its name to "Southern Pump Industry" effective May 21 [31] - Hong Sifang's subsidiary plans to invest approximately 1.49 billion yuan in a new chemical materials and fertilizers industrial park [32] - Buchang Pharmaceutical's subsidiary has signed a research agreement for MF59 adjuvant with a pharmaceutical company [33] Group 10 - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project [34] - Zhuojin Co. has won a bid for a soil remediation project worth 67.68 million yuan [35] - Xinjiang Jiaojian has been awarded a contract for a highway project valued at 451 million yuan [36] Group 11 - China National Materials Energy's subsidiary has signed a contract for an EPC project in Uzbekistan worth approximately 1.252 billion yuan [37] - Ruixin Microelectronics' shareholder plans to reduce its stake by up to 2% [38] - Shanghai Yizhong's shareholder also plans to reduce its stake by up to 2% [39] Group 12 - Sanyou Medical's controlling shareholder plans to reduce its stake by up to 1.44% [40] - Hangdian Co.'s controlling shareholder plans to reduce its stake by up to 1.93% [41] - Shangwei New Materials' shareholder plans to reduce its stake by up to 3% [42] Group 13 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan [43] - Jiuhua Tourism plans to raise up to 500 million yuan through a private placement for various projects [44] - Yuegui Co. plans to raise up to 900 million yuan for several projects [46]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Science and Art City land project, which has an area of 108,600 square meters and a starting price of 2.067 billion yuan [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Technology plans to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials, with production expected to start in June 2025 [6] - Weifu High-Tech's subsidiary will establish a joint venture with Baolong Technology to expand the business of fully active suspension motor hydraulic pumps, with a registered capital of 400 million yuan [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chensan Technology's shareholder Shanghai Ruiwei will transfer 14.58 million shares, representing 6.27% of the company, to Hefei Guotou, with the transfer price set at 17.7 yuan per share [10] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, currently holding 42.16% of the company, with stock trading suspended for up to 10 days [11] - Baolong Technology's subsidiary will partner with Weifu High-Tech's subsidiary to develop and mass-produce core components for fully active suspension systems [12] Group 4 - Buchang Pharmaceutical's subsidiary has signed a commissioned research agreement with Fubicheng Pharmaceutical for the MF59 emulsion adjuvant [14] - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project, with a duration of five years [15] - Zhuojin Co., Ltd. has won a bid for a soil remediation project worth 67.68 million yuan, with an expected share of approximately 59.9 million yuan [16] - Xinjiang Jiaojian has been awarded a contract for the G3013 line Ucha to Kangsou highway project, with a bid amount of 451 million yuan [17] Group 5 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan for employee stock ownership plans, with a maximum repurchase price of 23 yuan per share [19]

Group 1 - Hongjing Technology signed a service contract for an intelligent computing project with a total amount of 597 million yuan, valid for 5 years [1] - Weifu High-Tech's subsidiary invested 220 million yuan to establish a joint venture with Shanghai Baolong Automotive Technology [2] - Zhongshan Public received approval for the registration of short-term financing bonds amounting to 2 billion yuan and medium-term notes of 3 billion yuan [3] Group 2 - Lianhua Technology established a venture capital fund with a total commitment of 200 million yuan, contributing 100 million yuan as a limited partner [4] - Changan Technology's shareholder signed an agreement to transfer 6.27% of the company's shares to Hefei State Capital Venture Investment [6] - Hangzhou Garden announced a cash dividend of 0.5 yuan per 10 shares, totaling 6.62 million yuan [8] Group 3 - Huamao Technology plans to acquire 100% equity of Fuchuang Youyue, leading to a temporary suspension of its stock [9] - Zhuojin Co. won a bid for a soil remediation project in Hefei with a contract value of 67.68 million yuan [10] - Shanghai Pharmaceuticals received FDA approval for two drugs, enhancing its product portfolio [10] Group 4 - Fuxing Pharmaceutical's senior vice president resigned for personal reasons [12] - Baolong Technology's subsidiary plans to invest 180 million yuan in a joint venture [13] - ST Zhongdi intends to utilize surplus funds from a project company, with a maximum of 106 million yuan [14] Group 5 - Nanchao Food reported a significant decline in net profit for April, down 82.14% year-on-year [16] - Changshan Pharmaceutical received a drug registration certificate in Belarus for a new product [18] - Nanshan Aluminum established a wholly-owned subsidiary for photovoltaic energy projects with an investment of 5 million yuan [20] Group 6 - Bozhong Precision announced the resignation of a director and deputy general manager [22] - Xinjiang Jiaojian won a bid for a highway construction project valued at 451 million yuan [23] - Guangzhou Restaurant declared a cash dividend of 0.48 yuan per share, totaling 273 million yuan [25] Group 7 - Weili Medical's subsidiary obtained a medical device operating license, allowing it to engage in wholesale activities [27] - New Australia Co. announced a cash dividend of 0.3 yuan per share, totaling 219 million yuan [28] - Lianhua Technology's subsidiary entered the new third board innovation layer [29] Group 8 - Huaxi Energy's chairman resigned due to personal reasons [31] - Yipin Hong plans to use up to 500 million yuan of idle funds for cash management [33] - Shouhua Gas intends to purchase bauxite resources through market means [34] Group 9 - Jincheng signed a service agreement for underground mining operations at the Komakau Copper Mine, valued at approximately 805 million USD [34] - Wanrun New Energy signed a supply contract with CATL for lithium iron phosphate products, with a total supply of about 1.32 million tons [35] - Weili plans to transfer 100% equity of a subsidiary to Chengfa Environment for 100 million yuan [36] Group 10 - Zhenlei Technology's subsidiary received government subsidies of 2.21 million yuan, positively impacting profits [38] - Weir shares plan to change their name to "Haowei Group" to reflect strategic direction [39] - YTO Express reported a revenue increase of 16.32% in April, totaling 5.755 billion yuan [39]

证券代码：000581 200581 证券简称：威孚高科 苏威孚B 公告编号：2025-040 无锡威孚高科技集团股份有限公司 关于控股子公司对外投资设立合资公司的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、对外投资概述 为把握汽车全主动悬架系统应用发展趋势，抓住全主动悬架电机液压泵技术业务 发展机会，实现业务的快速增长和长期可持续发展。无锡威孚高科技集团股份有限公司 （以下简称"威孚高科"或"公司"）控股子公司南京威孚金宁有限公司（以下简称"威 孚金宁"）将与上海保隆汽车科技股份有限公司（以下简称"保隆科技"）的全资子 公司上海保隆汽车科技（安徽）有限公司（以下简称"合肥保隆"）共同投资设立威 孚保隆科技有限公司（以下简称"合资公司"，企业名称暂定，以工商登记机关最终 核准登记的名称为准）。合资公司拟注册资本人民币40,000万元，其中威孚金宁以货 币出资人民币22,000万元（占比55%）；合肥保隆以货币出资人民币18,000万元（占比 45%）；本次交易完成后，合资公司将成为威孚金宁控股子公司，纳入公司合并报表 范围。 公司于 2025 ...

证券代码: 000581 200581 证券简称：威孚高科 苏威孚 B 公告编号: 2025-039 无锡威孚高科技集团股份有限公司 第十一届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 表决结果：11 票同意、0 票反对、0 票弃权 具体内容详见 2025 年 5 月 21 日巨潮资讯网（http://www.cninfo.com.cn）刊登的公 司《关于控股子公司对外投资设立合资公司的公告》（公告编号：2025-040）。 3、会议应参加董事 11 人（尹震源、Kirsch Christoph、荣斌、冯志明、Xu Daquan、 赵红、黄睿、邢敏、冯凯燕、潘兴高、杨福源），实际参加董事 11 人。 4、会议由董事长尹震源先生召集并主持。 5、会议的召集、召开符合《公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 （一）审议通过了《关于控股子公司对外投资设立合资公司的议案》 一、董事会会议召开情况 1、无锡威孚高科技集团股份有限公司第十一届董事会第八次会议于 2025 年 5 月 14 日以电子邮件和电话的方式通知各位 ...

Core Viewpoint - The company is establishing a joint venture, "Weifu Baolong Technology Co., Ltd.", with Weifu High Technology Group's subsidiary to capitalize on the growing demand for fully active suspension systems in the automotive industry [1][8]. Group 1: Joint Venture Details - The joint venture will have a registered capital of RMB 400 million, with Hefei Baolong contributing RMB 180 million (45%) and Weifu Jinning contributing RMB 220 million (55%) [1][2]. - The establishment of the joint venture was approved by the company's board of directors on May 20, 2025, and does not require shareholder approval [1][2]. Group 2: Financial and Operational Aspects - Weifu Jinning, the partner in the joint venture, has a registered capital of approximately RMB 346.29 million and operates in various sectors including automotive parts production and sales [2][3]. - The joint venture aims to integrate Baolong's expertise in air suspension systems with Weifu's strengths in hydraulic pumps to develop core components for fully active suspension systems [8]. Group 3: Market Implications - The fully active suspension system is expected to enhance vehicle handling and comfort, with increasing demand from automotive manufacturers [8]. - The joint venture is positioned to fill a gap in the domestic supply of fully active suspension systems, promoting broader application in the Chinese automotive market [8].

保隆科技（603197）公告，公司全资子公司合肥保隆将与威孚高科（000581）控股子公司威孚金宁共同 投资设立"威孚保隆科技有限公司"。合资公司拟注册资本人民币4亿元，其中合肥保隆认缴出资人民币 1.8亿元，占注册资本的45%；威孚金宁认缴出资人民币2.2亿元，占注册资本的55%。合资公司设立尚 需通过市场监督管理部门等有关审批机关的核准，是否能如期设立合资公司存在不确定性。在未来实际 经营中，合资公司可能面临宏观经济、国家政策、行业周期、市场竞争等不确定因素，敬请广大投资者 注意投资风险。 ...

Mergers and Acquisitions - Harbin Pharmaceutical Group plans to acquire 42.82% equity of Sanjing Qianhe Pharmaceutical for 23.446 million yuan [1] - Xinjiang Torch intends to purchase 100% equity of Yushan Litai for 125 million yuan, which is classified as a related party transaction but not a major asset restructuring [2] Share Buybacks - Rongxin Culture announces a share buyback plan with a budget between 20 million and 22 million yuan, with a maximum buyback price of 37 yuan per share [3] - Weifu High Science plans to repurchase shares with a budget of 100 million to 150 million yuan, with a maximum buyback price of 35 yuan per share [4] Shareholding Changes - Hubei Yihua's controlling shareholder plans to increase its stake in the company by investing between 200 million and 400 million yuan within six months starting from May 19, 2025, without a price range [5] - Fuchuang Precision announces that two shareholders plan to collectively reduce their holdings by up to 4% of the total shares [6] - Hanchuan Intelligent's controlling shareholder received a warning from Jiangsu Securities Regulatory Commission for failing to disclose significant risks related to pledge contracts [7] - Delin Hai's shareholder plans to reduce holdings by up to 3% of the total shares due to personal financial needs [8]